Continued Access Protocol

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Atrial Fibrillation
Interventions
DEVICE

Arctic Front Cardiac Cryoablation System

The CryoCath Arctic Front® Cardiac CryoAblation Catheter System, including the Freezor MAX Cardiac Cryoablation Catheter, is indicated for the treatment of patients with paroxysmal atrial fibrillation to reduce the likelihood of subsequent detectable atrial fibrillation.

Trial Locations (10)

22042

Inova Research Center, Falls Church

23219

Virginia Commonwealth University Health System, Richmond

30309

Piedmont Hospital, Atlanta

33607

Bay Heart Group, Tampa

55905

Mayo Clinic, Rochester

75226

Baylor Heart & Vascular Hospital, Dallas

85006

Banner Good Samaritan, Phoenix

90048

Cedars Sinai Medical Center, Los Angeles

94305-5288

Stanford Hospital & Clinical, Stanford

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY